位置:首页 > 蛋白库 > IPA3_SHIFL
IPA3_SHIFL
ID   IPA3_SHIFL              Reviewed;         571 AA.
AC   Q83RJ4;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   25-MAY-2022, entry version 102.
DE   RecName: Full=E3 ubiquitin-protein ligase ipaH3;
DE            EC=2.3.2.27;
DE   AltName: Full=RING-type E3 ubiquitin transferase ipaH3 {ECO:0000305};
GN   Name=ipaH3; OrderedLocusNames=SF1383;
OS   Shigella flexneri.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=301 / Serotype 2a;
RX   PubMed=12384590; DOI=10.1093/nar/gkf566;
RA   Jin Q., Yuan Z., Xu J., Wang Y., Shen Y., Lu W., Wang J., Liu H., Yang J.,
RA   Yang F., Zhang X., Zhang J., Yang G., Wu H., Qu D., Dong J., Sun L.,
RA   Xue Y., Zhao A., Gao Y., Zhu J., Kan B., Ding K., Chen S., Cheng H.,
RA   Yao Z., He B., Chen R., Ma D., Qiang B., Wen Y., Hou Y., Yu J.;
RT   "Genome sequence of Shigella flexneri 2a: insights into pathogenicity
RT   through comparison with genomes of Escherichia coli K12 and O157.";
RL   Nucleic Acids Res. 30:4432-4441(2002).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), FUNCTION, UBIQUITINATION, DOMAIN,
RP   LEUCINE-RICH REPEATS, AND MUTAGENESIS OF CYS-363 AND ASP-365.
RC   STRAIN=301 / Serotype 2a;
RX   PubMed=18997779; DOI=10.1038/nsmb.1517;
RA   Zhu Y., Li H., Hu L., Wang J., Zhou Y., Pang Z., Liu L., Shao F.;
RT   "Structure of a Shigella effector reveals a new class of ubiquitin
RT   ligases.";
RL   Nat. Struct. Mol. Biol. 15:1302-1308(2008).
CC   -!- FUNCTION: Effector proteins function to alter host cell physiology and
CC       promote bacterial survival in host tissues. This protein is an E3
CC       ubiquitin ligase that interferes with host's ubiquitination pathway.
CC       Synthesizes a 'Lys-48'-linked ubiquitin chain, which requires non-
CC       covalent binding between ubiquitin and the host ubiquitin-conjugating
CC       enzyme UBE2D1. {ECO:0000269|PubMed:18997779}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Host cytoplasm
CC       {ECO:0000250}. Note=Secreted via Mxi-Spa type III secretion system
CC       (TTSS), and delivered into the host cytoplasm. {ECO:0000250}.
CC   -!- DOMAIN: The LRR (leucine-rich repeat) domain forms a slightly curved
CC       solenoid and may mediate interaction with target proteins.
CC       {ECO:0000269|PubMed:18997779}.
CC   -!- PTM: Ubiquitinated in the presence of host E1 ubiquitin-activating
CC       enzyme, E2 ubiquitin-conjugating enzyme UBE2D3 and ubiquitin.
CC       {ECO:0000269|PubMed:18997779}.
CC   -!- SIMILARITY: Belongs to the LRR-containing bacterial E3 ligase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE005674; AAN42986.1; -; Genomic_DNA.
DR   RefSeq; NP_707279.1; NC_004337.2.
DR   PDB; 3CVR; X-ray; 2.80 A; A=1-571.
DR   PDBsum; 3CVR; -.
DR   AlphaFoldDB; Q83RJ4; -.
DR   SMR; Q83RJ4; -.
DR   STRING; 198214.SF1383; -.
DR   EnsemblBacteria; AAN42986; AAN42986; SF1383.
DR   GeneID; 1024395; -.
DR   KEGG; sfl:SF1383; -.
DR   PATRIC; fig|198214.7.peg.1628; -.
DR   HOGENOM; CLU_018533_2_0_6; -.
DR   EvolutionaryTrace; Q83RJ4; -.
DR   Proteomes; UP000001006; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR032674; LRR_E3_ligase_N.
DR   InterPro; IPR029487; NEL_dom.
DR   Pfam; PF14496; NEL; 1.
DR   Pfam; PF12468; TTSSLRR; 1.
DR   PROSITE; PS51450; LRR; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Host cytoplasm; Leucine-rich repeat; Reference proteome;
KW   Repeat; Secreted; Transferase; Ubl conjugation; Ubl conjugation pathway;
KW   Virulence.
FT   CHAIN           1..571
FT                   /note="E3 ubiquitin-protein ligase ipaH3"
FT                   /id="PRO_0000391754"
FT   REPEAT          58..81
FT                   /note="LRR 1"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          83..99
FT                   /note="LRR 2"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          100..119
FT                   /note="LRR 3"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          120..144
FT                   /note="LRR 4"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          146..159
FT                   /note="LRR 5"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          160..184
FT                   /note="LRR 6"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          186..202
FT                   /note="LRR 7"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          205..229
FT                   /note="LRR 8"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REPEAT          232..260
FT                   /note="LRR 9"
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   REGION          1..260
FT                   /note="Interaction with target proteins"
FT   REGION          269..278
FT                   /note="Linker"
FT   REGION          279..571
FT                   /note="E3 ubiquitin-protein ligase catalytic domain"
FT   ACT_SITE        363
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         363
FT                   /note="C->A,S: Loss of ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   MUTAGEN         365
FT                   /note="D->N: Loss of ubiquitin ligase activity, but acts as
FT                   a thioesterase that uses Cys-363 to hydrolyze the
FT                   ubiquitin-E2 thioester."
FT                   /evidence="ECO:0000269|PubMed:18997779"
FT   HELIX           26..37
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           46..58
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          83..86
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          144..146
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          164..166
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          210..213
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           224..228
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          233..236
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           244..255
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          263..265
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           282..285
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           296..301
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   TURN            302..305
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           309..321
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   TURN            322..325
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           331..344
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           346..358
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           367..383
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   TURN            384..386
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           392..416
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          420..422
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           424..435
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   TURN            436..440
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   STRAND          448..450
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           458..481
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           484..492
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           495..504
FT                   /evidence="ECO:0007829|PDB:3CVR"
FT   HELIX           543..559
FT                   /evidence="ECO:0007829|PDB:3CVR"
SQ   SEQUENCE   571 AA;  64943 MW;  B0DF655E1540D77D CRC64;
     MSIMLPINNN FSLSQNSFYN TISGTYADYF SAWDKWEKQA LPGENRNEAV SLLKECLINQ
     FSELQLNRLN LSSLPDNLPP QITVLEITQN ALISLPELPA SLEYLDACDN RLSTLPELPA
     SLKHLDVDNN QLTMLPELPA LLEYINADNN QLTMLPELPT SLEVLSVRNN QLTFLPELPE
     SLEALDVSTN LLESLPAVPV RNHHSEETEI FFRCRENRIT HIPENILSLD PTCTIILEDN
     PLSSRIRESL SQQTAQPDYH GPRIYFSMSD GQQNTLHRPL ADAVTAWFPE NKQSDVSQIW
     HAFEHEEHAN TFSAFLDRLS DTVSARNTSG FREQVAAWLE KLSTSAELRQ QSFAVAADAT
     ESCEDRVALT WNNLRKTLLV HQASEGLFDN DTGALLSLGR EMFRLEILED IARDKVRTLH
     FVDEIEVYLA FQTMLAEKLQ LSTAVKEMRF YGVSGVTAND LRTAEAMVRS REENEFTDWF
     SLWGPWHAVL KRTEADRWAQ AEEQKYEMLE NEYSQRVADR LKASGLSGDA DAEREAGAQV
     MRETEQQIYR QVTDEVLALR LSENGSQLHH S
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024